Industry news

NSF-DBA experts bring you the latest news updates from the industry

GMP for API's Concept Paper

Wednesday the 8th February 2012

Dear All,

In late January 2012 the Commission published a Concept Paper on extending the scope of the current GMP Directive 2003/94/EC to cover APIs. The reason for this is proposal is given as the implementation of Directive 2011/62/EU and the need to bring a coherent approach across the EU. This proposal is thus being made to ensure that there is a ‘level playing field’ in the legal provisions relating to API GMP across the EU.

The Concept Paper proposes the following:

• “… all provisions in that Directive which currently address the manufacturing or manufacturer of medicinal products would also apply to the manufacturing and manufacturer of active substances.”
• However, some provisions will not apply to APIs:
o Marketing Authorisations
o Qualified Persons
o Manufacturing Authorisations

Adoption of the new Directive is planned for 2013. It is proposed that Member States will have just 6 months after the publication of a revised GMP Directive to transpose it into national law and it will have to be implemented just 3 months later.

Comments on the Concept Paper should be submitted by 20 April 2012.

Best regards,

Pete
Peter Gough, Partner
NSF-DBA Ltd.

Quick links

NSF-DBA have offices in Kirkbymoorside and Sheffield, UK and Boston and Ann Arbor, USA

A word from NSF-DBA

The legislation and guidance that apply to the healthcare industries is forever changing. NSF-DBA will provide you with regular updates on what is new and will also provide you with expert interpretation of these changes - what they mean

Peter Gough

© NSF-DBA 2013

Registered Office: NSF-DBA, The Georgian House, 22/24 West End, Kirkbymoorside, York, UK, YO62 6AF
Registered in England and Wales No: 3432550 | Tel: +44(0)1751 432999 | Fax: +44(0)1751 432450 | Email: mail@nsf-dba.com
US Office: NSF-DBA LLC, 6th floor, 129 South St, Boston, MA 02111 | Tel: 1-857-277-0060 | Fax: 1-857-284-7207 | Email: USinfo@nsf-dba.com